Group One Trading
PMVP icon

Group One Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Group One Trading’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121 Hold
90
– – ﹤0.01% 7397
2026
Q1 		$112 Buy
+90
New +$114 ﹤0.01% 7423
2025
Q3 		– Sell
-7,396
Closed -$10.2K – 8976
2025
Q2 		$7.84K Sell
7,396
-3,900
-35% -$3.83K ﹤0.01% 6870
2025
Q1 		$12.3K Sell
11,296
-3,687
-25% -$5.01K ﹤0.01% 6119
2024
Q4 		$22.6K Sell
14,983
-1,000
-6% -$1.58K ﹤0.01% 5609
2024
Q3 		$23.8K Buy
15,983
+3,133
+24% +$4.84K ﹤0.01% 5141
2024
Q2 		$20.8K Sell
12,850
-3,000
-19% -$5.41K ﹤0.01% 5197
2024
Q1 		$26.9K Buy
15,850
+9,671
+157% +$18.1K ﹤0.01% 5203
2023
Q4 		$19.2K Sell
6,179
-5,659
-48% -$15K ﹤0.01% 5777
2023
Q3 		$72.7K Buy
11,838
+10,819
+1,062% +$74.4K ﹤0.01% 4754
2023
Q2 		$6.38K Buy
1,019
+811
+390% +$4.25K ﹤0.01% 6605
2023
Q1 		$992 Sell
208
-3,474
-94% -$24.4K ﹤0.01% 6789
2022
Q4 		$32K Buy
+3,682
New +$39.2K ﹤0.01% 5295

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Group One Trading's PMVP Position: Q2 2026 in Review

Group One Trading held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 90 shares worth $121. The position accounts for ﹤0.01% of the portfolio, ranked #7397.

Group One Trading first reported a position in PMVP in Q4 2022 and has held it in 13 quarters since. The position peaked at $72.7K in Q3 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Group One Trading held 90 shares of PMV Pharmaceuticals worth $121 as of Q2 2026.
  • Group One Trading left its PMV Pharmaceuticals share count unchanged in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7397 holding.
  • Group One Trading first reported a position in PMV Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • Group One Trading's PMV Pharmaceuticals position peaked at $72.7K in Q3 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.